<?xml version="1.0"  encoding="UTF-8"?>
<prs:study_collection xmlns:prs="http://clinicaltrials.gov/prs">
<clinical_study>
<id_info>
<provider_name>NLM_DES</provider_name>
<provider_study_id>S0006HWA</provider_study_id>
<org_name>AddenbrookesH</org_name>
<org_study_id>1234</org_study_id>
</id_info>
<is_fda_regulated>No</is_fda_regulated>
<is_section_801>None</is_section_801>
<delayed_posting>None</delayed_posting>
<is_ind_study>No</is_ind_study>
<brief_title>Test Study for my tool</brief_title>
<acronym>TEST</acronym>
<official_title>Test Study for my tool</official_title>
<sponsors>
<lead_sponsor>
<agency>Cambridge University Hospitals NHS Foundation Trust</agency>
</lead_sponsor>
<resp_party>
<resp_party_type>Principal Investigator</resp_party_type>
<investigator_username>djayne</investigator_username>
<investigator_title>Dr</investigator_title>
<investigator_affiliation>Cambridge University Hospitals NHS Foundation Trust</investigator_affiliation>
<name_title/>
<organization/>
<phone/>
<phone_ext/>
<email/>
</resp_party>
</sponsors>
<oversight_info>
<irb_info>
<approval_status>Exempt</approval_status>
</irb_info>
<has_dmc>No</has_dmc>
<fda_regulated_drug>No</fda_regulated_drug>
<fda_regulated_device>No</fda_regulated_device>
<post_prior_to_approval>None</post_prior_to_approval>
</oversight_info>
<brief_summary>
<textblock>Test Trial </textblock>
</brief_summary>
<detailed_description>
<textblock></textblock>
</detailed_description>
<overall_status>Completed</overall_status>
<why_stopped/>
<verification_date>2021-07</verification_date>
<start_date>2020-01-01</start_date>
<start_date_type>Actual</start_date_type>
<end_date/>
<last_follow_up_date>2021-02-01</last_follow_up_date>
<last_follow_up_date_type>Actual</last_follow_up_date_type>
<primary_compl_date>2021-01-01</primary_compl_date>
<primary_compl_date_type>Actual</primary_compl_date_type>
<study_design>
<study_type>Interventional</study_type>
<interventional_design>
<interventional_subtype>Treatment</interventional_subtype>
<phase>Phase 2</phase>
<assignment>Parallel Assignment</assignment>
<model_description>
<textblock></textblock>
</model_description>
<allocation>Randomized</allocation>
<masking/>
<no_masking>true</no_masking>
<masked_subject>false</masked_subject>
<masked_caregiver>false</masked_caregiver>
<masked_investigator>false</masked_investigator>
<masked_assessor>false</masked_assessor>
<masking_description>
<textblock></textblock>
</masking_description>
<control/>
<number_of_arms>2</number_of_arms>
</interventional_design>
</study_design>
 
<enrollment>400</enrollment>
<enrollment_type>Actual</enrollment_type>
<condition>Vasculitis</condition>
<arm_group>
<arm_group_label>Control</arm_group_label>
<arm_type>No Intervention</arm_type>
<arm_group_description>
<textblock></textblock>
</arm_group_description>
</arm_group>
<arm_group>
<arm_group_label>Ritazarem</arm_group_label>
<arm_type>Experimental</arm_type>
<arm_group_description>
<textblock></textblock>
</arm_group_description>
</arm_group>
<intervention>
<intervention_type>Drug</intervention_type>
<intervention_name>ritazarem</intervention_name>
<intervention_description>
<textblock>A drug that we want to look at</textblock>
</intervention_description>
<arm_group_label>Ritazarem</arm_group_label>
</intervention>
<eligibility>
<study_population>
<textblock></textblock>
</study_population>
<sampling_method/>
<criteria>
<textblock>Inclusion Criteria:&#xd;
- Vasculitis&#xd;
&#xd;
Exclusion Criteria:&#xd;
- </textblock>
</criteria>
<healthy_volunteers>No</healthy_volunteers>
<gender>All</gender>
<gender_based>No</gender_based>
<gender_description>
<textblock></textblock>
</gender_description>
<minimum_age>18 Years</minimum_age>
<maximum_age> N/A</maximum_age>
</eligibility>
<overall_contact>
<first_name>Simon</first_name>
<middle_name/>
<last_name>Bond</last_name>
<degrees/>
<phone>+441223596475</phone>
<phone_ext/>
<email>simon.bond@addenbrookes.nhs.uk</email>
</overall_contact>
<overall_contact_backup>
<first_name/>
<middle_name/>
<last_name/>
<degrees/>
<phone/>
<phone_ext/>
<email/>
</overall_contact_backup>
<location>
<facility>
<name>Cambridge Clinical Trials Unit</name>
<address>
<city>Cambridge</city>
<state/>
<country>United Kingdom</country>
<zip>cb20qq</zip>
</address>
</facility>
<status>Completed</status>
<contact>
<first_name>Simon</first_name>
<middle_name/>
<last_name>Bond</last_name>
<degrees/>
<phone>01223596475</phone>
<phone_ext/>
<email>simon.bond@addenbrookes.nhs.uk</email>
</contact>
<contact_backup>
<first_name/>
<middle_name/>
<last_name/>
<degrees/>
<phone/>
<phone_ext/>
<email/>
</contact_backup>
</location>
<ipd_sharing_statement>
<sharing_ipd>No</sharing_ipd>
<ipd_description>
<textblock></textblock>
</ipd_description>
<ipd_info_type_protocol>false</ipd_info_type_protocol>
<ipd_info_type_sap>false</ipd_info_type_sap>
<ipd_info_type_icf>false</ipd_info_type_icf>
<ipd_info_type_csr>false</ipd_info_type_csr>
<ipd_info_type_analytic_code>false</ipd_info_type_analytic_code>
<ipd_time_frame>
<textblock></textblock>
</ipd_time_frame>
<ipd_access_criteria>
<textblock></textblock>
</ipd_access_criteria>
<ipd_url>http://</ipd_url>
</ipd_sharing_statement>
<rrs:result xmlns:rrs="http://clinicaltrials.gov/rrs">
<certainAgreement/>
<outcomeMeasures>
<outcomeMeasure>
<measureRows/>
<measureDescription/>
 
<timeFrame/>
<title>Time to relapse</title>
<anticipatedResultPostingDate/>
<measureType>Primary</measureType>
<outcomeMeasureAnalyses/>
<outcomeReportingGroups/>
</outcomeMeasure>
</outcomeMeasures>
<pointOfContact/>
 
<reportedEvents>
<allCauseMortComment>all-cause mortality</allCauseMortComment>
<assessmentType>Non-Systematic Assessment</assessmentType>
<frequencyReportingThreshold>0.0</frequencyReportingThreshold>
<frequentAdverseEvents>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Neutropenia</notes>
<organSystemName>Blood and lymphatic system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Neutropenia</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Acute coronary syndrome</notes>
<organSystemName>Cardiac disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Acute coronary syndrome</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Acute myocardial infarction</notes>
<organSystemName>Cardiac disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Acute myocardial infarction</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Angina pectoris</notes>
<organSystemName>Cardiac disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Angina pectoris</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Atrial fibrillation</notes>
<organSystemName>Cardiac disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Atrial fibrillation</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Atrioventricular block complete</notes>
<organSystemName>Cardiac disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Atrioventricular block complete</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Abdominal pain</notes>
<organSystemName>Gastrointestinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Abdominal pain</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Duodenal ulcer</notes>
<organSystemName>Gastrointestinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Duodenal ulcer</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Intestinal perforation</notes>
<organSystemName>Gastrointestinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Intestinal perforation</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pyrexia</notes>
<organSystemName>General disorders and administration site conditions</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pyrexia</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Cholecystitis</notes>
<organSystemName>Hepatobiliary disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Cholecystitis</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Drug hypersensitivity</notes>
<organSystemName>Immune system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Drug hypersensitivity</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Hypersensitivity</notes>
<organSystemName>Immune system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Hypersensitivity</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>4</numEvents>
<numSubjectsAffected>3</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>3</numEvents>
<numSubjectsAffected>3</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Vasculitis</notes>
<organSystemName>Immune system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Vasculitis</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Escherichia urinary tract infec</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Escherichia urinary tract infec</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Influenza</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Influenza</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>2</numEvents>
<numSubjectsAffected>2</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>4</numEvents>
<numSubjectsAffected>3</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumonia</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumonia</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumonia pseudomonal</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumonia pseudomonal</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>2</numEvents>
<numSubjectsAffected>2</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Respiratory tract infection</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Respiratory tract infection</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Sinusitis</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Sinusitis</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Urinary tract infection</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Urinary tract infection</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Wound dehiscence</notes>
<organSystemName>Injury, poisoning and procedural complications</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Wound dehiscence</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Dehydration</notes>
<organSystemName>Metabolism and nutrition disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Dehydration</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Osteoarthritis</notes>
<organSystemName>Musculoskeletal and connective tissue disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Osteoarthritis</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Anal squamous cell carcinoma</notes>
<organSystemName>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Anal squamous cell carcinoma</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Squamous cell carcinoma</notes>
<organSystemName>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Squamous cell carcinoma</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>2</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Sleep apnoea syndrome</notes>
<organSystemName>Nervous system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Sleep apnoea syndrome</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Enterovesical fistula</notes>
<organSystemName>Renal and urinary disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Enterovesical fistula</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Renal impairment</notes>
<organSystemName>Renal and urinary disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Renal impairment</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Bronchospasm</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Bronchospasm</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Dyspnoea</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Dyspnoea</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Laryngeal stenosis</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Laryngeal stenosis</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Lower respiratory tract infecti</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Lower respiratory tract infecti</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Lung adenocarcinoma</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Lung adenocarcinoma</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumonia</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumonia</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumonia streptococcal</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumonia streptococcal</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumonitis</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumonitis</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Respiratory failure</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Respiratory failure</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Colostomy closure</notes>
<organSystemName>Surgical and medical procedures</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Colostomy closure</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Aortic dissection</notes>
<organSystemName>Vascular disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Aortic dissection</term>
</frequentEvent>
<frequentEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Deep vein thrombosis</notes>
<organSystemName>Vascular disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Deep vein thrombosis</term>
</frequentEvent>
</frequentAdverseEvents>
<interventionGroups>
<interventionGroup id="d23e3">
<description>Control</description>
<numDeaths>9</numDeaths>
<numSubjectsFrequentEvents>15</numSubjectsFrequentEvents>
<numSubjectsSeriousEvents>15</numSubjectsSeriousEvents>
<partAtRiskAllCauseMort>60</partAtRiskAllCauseMort>
<partAtRiskFrequentEvents>60</partAtRiskFrequentEvents>
<partAtRiskSeriousEvents>60</partAtRiskSeriousEvents>
<title>Control</title>
</interventionGroup>
<interventionGroup id="d23e16">
<description>Experimental</description>
<numDeaths>22</numDeaths>
<numSubjectsFrequentEvents>24</numSubjectsFrequentEvents>
<numSubjectsSeriousEvents>32</numSubjectsSeriousEvents>
<partAtRiskAllCauseMort>67</partAtRiskAllCauseMort>
<partAtRiskFrequentEvents>67</partAtRiskFrequentEvents>
<partAtRiskSeriousEvents>67</partAtRiskSeriousEvents>
<title>Experimental</title>
</interventionGroup>
</interventionGroups>
<notes/>
<seriousAdverseEvents>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>B-cell lymphoma</notes>
<organSystemName>Blood and lymphatic system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>B-cell lymphoma</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Cardiac arrest</notes>
<organSystemName>Cardiac disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Cardiac arrest</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Cardiac failure congestive</notes>
<organSystemName>Cardiac disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Cardiac failure congestive</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Abdominal pain</notes>
<organSystemName>Gastrointestinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Abdominal pain</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Gastroenteritis viral</notes>
<organSystemName>Gastrointestinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Gastroenteritis viral</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Gastrointestinal haemorrhage</notes>
<organSystemName>Gastrointestinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Gastrointestinal haemorrhage</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Oesophageal spasm</notes>
<organSystemName>Gastrointestinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Oesophageal spasm</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Oesophagitis</notes>
<organSystemName>Gastrointestinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Oesophagitis</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Chest pain</notes>
<organSystemName>General disorders and administration site conditions</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Chest pain</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Cholecystitis acute</notes>
<organSystemName>Hepatobiliary disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Cholecystitis acute</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pulmonary vasculitis</notes>
<organSystemName>Immune system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pulmonary vasculitis</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>2</numEvents>
<numSubjectsAffected>2</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Vasculitis</notes>
<organSystemName>Immune system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Vasculitis</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Cellulitis</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Cellulitis</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Escherichia urinary tract infec</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Escherichia urinary tract infec</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Gastroenteritis Escherichia col</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Gastroenteritis Escherichia col</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Influenza</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Influenza</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Lower respiratory tract infecti</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Lower respiratory tract infecti</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>3</numEvents>
<numSubjectsAffected>3</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumonia</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumonia</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>2</numEvents>
<numSubjectsAffected>2</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Respiratory tract infection</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Respiratory tract infection</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>2</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Urinary tract infection</notes>
<organSystemName>Infections and infestations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Urinary tract infection</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Fall</notes>
<organSystemName>Injury, poisoning and procedural complications</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Fall</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Post procedural complication</notes>
<organSystemName>Injury, poisoning and procedural complications</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Post procedural complication</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Medical observation</notes>
<organSystemName>Investigations</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Medical observation</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Hyperglycaemia</notes>
<organSystemName>Metabolism and nutrition disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Hyperglycaemia</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Hyperkalaemia</notes>
<organSystemName>Metabolism and nutrition disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Hyperkalaemia</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Bladder papilloma</notes>
<organSystemName>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Bladder papilloma</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Cerebrovascular accident</notes>
<organSystemName>Nervous system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Cerebrovascular accident</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Sleep apnoea syndrome</notes>
<organSystemName>Nervous system disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Sleep apnoea syndrome</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Conversion disorder</notes>
<organSystemName>Psychiatric disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Conversion disorder</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Proteinuria</notes>
<organSystemName>Renal and urinary disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Proteinuria</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>4</numEvents>
<numSubjectsAffected>2</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Laryngeal stenosis</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Laryngeal stenosis</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumomediastinum</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumomediastinum</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumonia klebsiella</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumonia klebsiella</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumonia staphylococcal</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumonia staphylococcal</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pneumonia viral</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pneumonia viral</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pulmonary embolism</notes>
<organSystemName>Respiratory, thoracic and mediastinal disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pulmonary embolism</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Aortic valve replacement</notes>
<organSystemName>Surgical and medical procedures</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Aortic valve replacement</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Cholecystectomy</notes>
<organSystemName>Surgical and medical procedures</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Cholecystectomy</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Dacryocystorhinostomy</notes>
<organSystemName>Surgical and medical procedures</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Dacryocystorhinostomy</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>2</numEvents>
<numSubjectsAffected>2</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Hip arthroplasty</notes>
<organSystemName>Surgical and medical procedures</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Hip arthroplasty</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>0</numEvents>
<numSubjectsAffected>0</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Small intestinal resection</notes>
<organSystemName>Surgical and medical procedures</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Small intestinal resection</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>3</numEvents>
<numSubjectsAffected>3</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Deep vein thrombosis</notes>
<organSystemName>Vascular disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Deep vein thrombosis</term>
</seriousEvent>
<seriousEvent>
<adverseEventStats>
<eventStats>
<reportingGroupId>d23e3</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>60</numSubjects>
</eventStats>
<eventStats>
<reportingGroupId>d23e16</reportingGroupId>
<numEvents>1</numEvents>
<numSubjectsAffected>1</numSubjectsAffected>
<numSubjects>67</numSubjects>
</eventStats>
</adverseEventStats>
<assessmentType>Non-Systematic Assessment</assessmentType>
<notes>Pulmonary embolism</notes>
<organSystemName>Vascular disorders</organSystemName>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<term>Pulmonary embolism</term>
</seriousEvent>
</seriousAdverseEvents>
<sourceVocabulary>MedDRA 22.0</sourceVocabulary>
<timeFrame>Timeframe for AE</timeFrame>
</reportedEvents>
 
</rrs:result></clinical_study>
</prs:study_collection>
